Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.

Perrone V, Veronesi C, Cappuccilli M, Andretta M, Bacca M, Barbieri A, Bartolini F, Brega A, Cillo MR, Colasuonno F, Dell'Orco S, Ferrante F, Grego S, Lavalle A, Mancini D, Pastorello M, Pagliaro R, Procacci C, Scandolara C, Schiavone P, Ubertazzo L, Valpondi P, Vercellone A, Zucchi A, Ciappetta M, Lucatelli D, Cinti Luciani A, Degli Esposti L

Open source

DOI: 10.1111/epi.18673
Published: 2026 Feb
Container: Epilepsia
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/epi.18673,
  title = {Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.},
  author = {Perrone V and Veronesi C and Cappuccilli M and Andretta M and Bacca M and Barbieri A and Bartolini F and Brega A and Cillo MR and Colasuonno F and Dell'Orco S and Ferrante F and Grego S and Lavalle A and Mancini D and Pastorello M and Pagliaro R and Procacci C and Scandolara C and Schiavone P and Ubertazzo L and Valpondi P and Vercellone A and Zucchi A and Ciappetta M and Lucatelli D and Cinti Luciani A and Degli Esposti L},
  year = {2026},
  journal = {Epilepsia},
  doi = {10.1111/epi.18673},
  url = {https://doi.org/10.1111/epi.18673}
}

RIS

TY  - JOUR
TI  - Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.
AU  - Perrone V
AU  - Veronesi C
AU  - Cappuccilli M
AU  - Andretta M
AU  - Bacca M
AU  - Barbieri A
AU  - Bartolini F
AU  - Brega A
AU  - Cillo MR
AU  - Colasuonno F
AU  - Dell'Orco S
AU  - Ferrante F
AU  - Grego S
AU  - Lavalle A
AU  - Mancini D
AU  - Pastorello M
AU  - Pagliaro R
AU  - Procacci C
AU  - Scandolara C
AU  - Schiavone P
AU  - Ubertazzo L
AU  - Valpondi P
AU  - Vercellone A
AU  - Zucchi A
AU  - Ciappetta M
AU  - Lucatelli D
AU  - Cinti Luciani A
AU  - Degli Esposti L
PY  - 2026
JO  - Epilepsia
DO  - 10.1111/epi.18673
UR  - https://doi.org/10.1111/epi.18673
ER  -

APA

V, P., C, V., M, C., M, A., M, B., A, B., F, B., A, B., MR, C., F, C., S, D., F, F., S, G., A, L., D, M., M, P., R, P., C, P., C, S., P, S., L, U., P, V., A, V., A, Z., M, C., D, L., A, C. L., & L, D. E. (2026). Characteristics, therapeutic pathway and the economic burden of patients with drug-resistant epilepsy: A real-world analysis following the introduction of cenobamate in Italy.. Epilepsia. https://doi.org/10.1111/epi.18673

Source records

pubmed · retrieved 2026-09-26T07:53:42.658Z